NeuroOne Medical Technologies Corporation Common Stock (NMTC)
NeuroOne Medical Technologies Corporation (NMTC) is a medical device company focused on developing and commercializing innovative neural interfaces and neurostimulation solutions. The company's technologies aim to improve diagnosis and treatment options for neurological disorders, such as epilepsy and chronic pain, by providing minimally invasive and precise neural interface solutions. Founded to advance neurotechnology, NeuroOne seeks to enhance patient outcomes through its specialized devices and ongoing research efforts.
Company News
NeuroOne Medical Technologies reported strong Q3 2025 performance with 105% product revenue growth, improved gross margins, and promising clinical milestones for its OneRF ablation system, including the first patient achieving 12-month seizure freedom.
NeuroOne Medical Technologies Corporation will release its fiscal first quarter 2025 financial results on February 12, 2025, and host an investor conference call to discuss the results and provide a corporate update.
NeuroOne Medical Technologies Corporation has been notified by Nasdaq that it is not in compliance with the minimum bid price requirement, and faces delisting if it fails to regain compliance within the grace period.
Gainers Aurora Acquisition Corp. (NASDAQ: AURC) shares jumped 192% to $30.54. Inpixon (NASDAQ: INPX) gained 117% to $0.33 after the company agreed to merge with XTI Aircraft Company. Electra Battery Materials Corporation (NASDAQ: ELBM) shares shot up 71.5% to $2.11 after jumping 22% on Monday. Electra Battery Materials said its battery grade co...
Biotech penny stocks to watch this week. Are they a buy now? The post Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.